Global Respiratory Inhaler Devices Market Share, Global Trends, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2015 Future Market Insights www.futuremarketinsights.com [email protected] Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends. We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC. Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and Retail. We have a global presence with delivery centers across India specializing in providing global research reports and country research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India. We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for our client. Research Capabilities Sector Coverage Customized Research Syndicated Research Investment Research Social Media Research Automotive and Transportation Electronics, Semiconductor, and ICT Retail and Consumer Products Industrial Automation and Equipment Customized Research Subscription Information Syndicated Research For detailed subscription information please contact Investment Research T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268 Social Media Research Hari. T (Sr. Manager - Global Business Development) Email: [email protected] Chemicals & Materials Food and Beverages Services and Utilities Energy, Mining, Oil, and Gas Report Description Report Description Respiratory inhaler is a device that delivers a specific amount of medication to the lungs, in the form of a short burst of aerosolized medicine that is usually self-administered by the patient via inhalation. It is the most commonly used medication delivery system for treating Asthma, Chronic Obstructive Pulmonary Disease (COPD) and other respiratory diseases. Asthma is a common chronic inflammatory disease of the airways characterized by variable and recurring symptoms, reversible airflow obstruction and bronchospasm. Common symptoms include wheezing, coughing, chest tightness, and shortness of breath. Whereas, COPD is the obstructive lung disease characterized by chronically poor airflow. It typically worsens over time. The main symptoms include shortness of breath, cough, and sputum production. Most people with chronic bronchitis have COPD. The primary cause of COPD is tobacco smoke (through tobacco use or second-hand smoke). As per WHO, Some 235 million people currently suffer from asthma and more than 3 million people died of COPD in 2012, which is equal to 6% of all deaths globally that year. Respiratory Inhaler Devices Market: Drivers and Restraints The respiratory inhaler devices market is driven by aging population and increasing respiratory disease among global population. Respiratory inhaler devices market will be driven by new technological advancements. The huge population afflicted with respiratory disorders such as asthma and chronic obstructive pulmonary disease will drive the Respiratory inhaler market. Report Description Report Description Browse Full Report@ http://www.futuremarketinsights.com/reports/respiratoryinhaler-devices-market Increasing focus among pediatric patients with COPD and Asthma. Also, awareness programmes by healthcare organization to increase adoption rate will drive this market. However, it is observed that the respiratory inhalers, particularly Metered Dose Inhaler (MDIs), release environmentally-hazardous gases, namely chlorofluorocarbon (CFC) and hydrofluoroalkanes (HFA), which is acting as a barrier in the adoption of such devices. Respiratory Inhaler Devices Market: Segmentation The global respiratory inhaler devices market is segmented into following devices: Dry Powder Inhalers Metered Dose Inhaler Nebulizers Considering the growth and market size, Metered Dose Inhalers (MDIs) are the largest revenue generating segment currently and is expected to grow at a higher rate in the forecast period. Respiratory Inhaler Devices Market: Overview With rapid technological advancement and wide acceptance of respiratory inhaler devices among patients with respiratory disorder, the global respiratory inhaler market is Report Description Report Description Request Report TOC@ http://www.futuremarketinsights.com/toc/rep-gb-493 Respiratory Inhaler Devices Market: Regional Outlook The global respiratory inhaler devices market is expected to register a significant growth for the forecast period. Depending on geographic regions, the global respiratory inhaler devices market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa. North America is the largest market for respiratory inhaler devices, followed by Europe and Asia. North America and Europe has a well-established pharmaceutical industry, which has stimulated the growth of the respiratory inhaler device market in these regions. The Asian market is expected to witness a double digit growth over the next five years, owing to the flourishing pharmaceutical industry, development of healthcare infrastructure, and rising disposable income. Respiratory Inhaler Devices Market: Key Players GlaxoSmithKline plc., Boehringer Ingelheim GmbH, AstraZeneca plc., Hospira Inc., Care Fusion Corporation, 3M Company are some of the major key players in Respiratory Inhaler devices global market. Thank You! To know more about us, please visit our website: www.futuremarketinsights.com For sales queries or new topics email us on: [email protected] For other queries contact: Mr. Sudip Saha Future Market Insights: 616 Corporate Way, Suite 2-9018, Valley Cottage, NY 10989, United States T: +1-347-918-3531 | D: +1-845-579-5705
Respiratory inhaler devices market will be driven by new technological advancements. The huge population afflicted with respiratory disorders such as asthma and chronic obstructive pulmonary disease will drive the Respiratory inhaler market. Increasing focus among pediatric patients with COPD and Asthma. Also, awareness programmes by healthcare organization to increase adoption rate will drive this market. However, it is observed that the respiratory inhalers, particularly Metered Dose Inhaler (MDIs), release environmentally-hazardous gases, namely chlorofluorocarbon (CFC) and hydrofluoroalkanes (HFA), which is acting as a barrier in the adoption of such devices.
© Copyright 2024 Paperzz
